Research Notes: Gene Editing and the New Natural
Behind the Research
When does “natural” human variation stop being something we accept and start being something we select against?
The trail began with Casgevy’s approval in late 2023. First CRISPR therapy hitting the market. Revolutionary, life-saving, and priced at $2.2 million per patient. That price point stuck with me. It’s not arbitrary. It’s exact…
